Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer

SIMPLE SUMMARY: Immunotherapy has emerged as an attractive alternative to conventional therapies for the clinical management of prostate cancer (PCa); it not only specifically targets malignant cells while protecting healthy tissue, but it also appears to augment the therapeutic effect of existing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamaki, Maria, Zoumpourlis, Vassilios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825410/
https://www.ncbi.nlm.nih.gov/pubmed/33419051
http://dx.doi.org/10.3390/cancers13020173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825410/
https://www.ncbi.nlm.nih.gov/pubmed/33419051
http://dx.doi.org/10.3390/cancers13020173

Ejemplares similares